Scarica l'app Stockscreener
35.56
3.24%
-1.19
Dopo l'orario di chiusura:
35.53
-0.03
-0.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VKTX Giù?
Forum
Previsione
Viking Therapeutics Inc Borsa (VKTX) Ultime notizie
Viking Therapeutics Stock (VKTX) Opinions on Positive Obesity Drug Data Release - Quiver Quantitative
What Viking Therapeutics Stock Means For Shareholders After Obesity Drug Data And $500 Million Raise - simplywall.st
VKTX 10-Q FilingsViking Therapeutics, Inc SEC 10-Q - stocktitan.net
VKTX Stock On Track To Beat LLY, NVO This Month After Obesity Drug Data — Can Viking Win Over Wegovy And Zepbound Users? - Stocktwits
Viking Therapeutics Adds Weight Loss Maintenance As Potential New Growth Driver (NASDAQ:VKTX) - Seeking Alpha
Is Viking Therapeutics (VKTX) Getting Too Rich After VK2735 Data? - finance.yahoo.com
Biotech Stocks To ResearchSeptember 25th - MarketBeat
VKTX Stock Outpaces LLY, ALT Ahead Of Earnings – Retail Eyes Breakout Ahead - Stocktwits
VKTX Form 4 FilingsViking Therapeutics, Inc SEC Form 4 - stocktitan.net
Is Viking Therapeutics, Inc. (VKTX) the Healthcare Stocks Stock Everyone's About to Talk About? - Kalkine Media
Form 424B5 Viking Therapeutics Inc For: 25 September - Investing.com India
Latham Advises on Viking Therapeutics’ Upsized US$500 Million Offering of Common Stock and Convertible Senior Notes - Legal Desire
Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy? - The Motley Fool
Form 424B5 Viking Therapeutics Inc For: 25 September By Investing.com - Investing.com Canada
Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy? - The Motley Fool
VKTX Stock Steady After-Hours On Positive Obesity Drug Pipeline Progress - Stocktwits
Viking Therapeutics (VKTX) Stock Looks Fully Priced Despite Its Huge Five Year Run - simplywall.st
VKTX Stock Reverses Weight-Loss Drug Gains As Viking Unveils $500M Discounted Financing - Stocktwits
VKTX Stock Lags GLP-1 Peers In July — But Viking CEO Says Its Obesity Drug Could Offer What Rivals Can’t - Stocktwits
Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Viking Therapeutics Plunges After Upsized $500 Million Financing Prices at 16% Discount - finance.biggo.com
Viking Therapeutics Share Drop After Upsized Stock, Notes Offerings - Moomoo
One investor reportedly took a third of Viking’s share sale - au.finance.yahoo.com
Viking Therapeutics raises USD 500m to advance VK2735 obesity program - AllSci
Latham Advises on Viking Therapeutics Upsized Offering of Common Stock and Convertible Senior Notes - Latham & Watkins LLP
Viking Therapeutics Advances VK2735 Obesity Trial, Keeping VKTX in the Weight Loss Race - TipRanks
Here's Why Viking Therapeutics Shares Slumped Today - The Motley Fool
Top Biotech Stocks To Keep An Eye OnSeptember 24th - MarketBeat
Why Is Viking Therapeutics Stock Trading Down Thursday? - Benzinga
Viking Therapeutics drops 15% after $500M stock offering; Jaguar Health falls 25% without news. - Pluang
Viking Therapeutics Sinks 12% on “Upsized” $500 Million Raise - TIKR.com
Viking Therapeutics Sinks 15% After Pricing Upsized $500M Offering; Jaguar Health Tumbles 25% - finance.yahoo.com
Biggest stock movers Thursday: P, VKTX, MGM, BE, and more - Seeking Alpha
Viking Therapeutics Prices Upsized Stock and Convertible Notes Offering at Discount - Intellectia AI
VKTX Stock Heads Toward Worst Day In Over A Year Just Days After Promising Weight Loss Drug Data — Here’s What’s Driving The Selloff - Yahoo Finance
What Did Viking Therapeutics (NASDAQ:VKTX) Maintenance Data Show for VK2735? - Kalkine Media
Viking Therapeutics Prices Upsized $500 Million Stock, Convertible Notes Offering - marketscreener.com
Viking Therapeutics (VKTX) Prices $490M Concurrent Offering Amid Unprofitable Growth Outlook - GuruFocus
Why is Viking Therapeutics stock tumbling today? By Investing.com - Investing.com Canada
Stitch Fix Posts Mixed Q4 Results, Joins Viking Therapeutics And Other Big Stocks Moving Lower In Thursda - Benzinga
Why is Viking Therapeutics stock tumbling today? - Investing.com
Viking Therapeutics raises $500M in upsized stock and notes offering - Dealroom
Viking Therapeutics prices $500M stock and debt offering - Investing.com
Viking Therapeutics prices $275M stock and conv... - Pluang
Viking Therapeutics prices $500M stock and debt offering By Investing.com - ng.investing.com
Viking Therapeutics prices upsized $500M offering of common stock and convertible senior notes - TradingView
Viking Therapeutics Prices Upsized $500 Million Offering Of Common Stock And Convertible Senior Notes - TradingView
Viking Therapeutics, Inc. (VKTX) Prices Upsized $500M Stock and 2.00% Convertible Notes - TradingView
VKTX Stock Eyes Blockbuster Week Despite Share Offering — Retail Traders See A Stronger Hand In Buyout Talks - Yahoo Finance
Positive VK2735 Clinical Data: Can Viking Therapeutics Displace Eli Lilly and Novo Nordisk? - NAI500
Is Viking Therapeutics (VKTX) Fully Valued On Its Positive VK2735 Trial Update? - simplywall.st
Viking Therapeutics Plans $400 Million Public Offerings - Intellectia AI
VKTX Stock Slides After-Hours On $400M Stock-And-Notes Raise After Tuesday’s Rally - finance.yahoo.com
Viking Therapeutics, Inc. (VKTX) Discusses Top Line Data from VK2735 Maintenance Study in Obesity and Type 2 DiabetesSlideshow (NASDAQ:VKTX) 2026-09-22 - Seeking Alpha
Form 424B5 Viking Therapeutics Inc For: 23 September By Investing.com - Investing.com Canada
Viking Therapeutics (VKTX) Plans $400M Capital Raise Amid Mixed Market Signals - GuruFocus
Viking Therapeutics, Inc. (VKTX) Gains As Market Dips: What You Should Know - Yahoo Finance
Viking Therapeutics (VKTX) Plans $400M Capital Raise via Stock a - GuruFocus
Viking Therapeutics Plans Offering of Common Shares, Senior Notes due 2032 - finance.yahoo.com
Viking Therapeutics Announces Proposed Offerings Of Common Stock And Convertible Senior Notes - TradingView
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):